Cargando…
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance
Advanced cutaneous melanoma is the deadliest form of skin cancer and one of the most aggressive human cancers. Targeted therapies (TT) against BRAF mutated melanoma and immune checkpoints blockade therapies (ICB) have been a breakthrough in the treatment of metastatic melanoma. However, therapy-driv...
Autores principales: | Diazzi, Serena, Tartare-Deckert, Sophie, Deckert, Marcel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922263/ https://www.ncbi.nlm.nih.gov/pubmed/36774337 http://dx.doi.org/10.1038/s41389-023-00452-8 |
Ejemplares similares
-
Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies
por: Diazzi, Serena, et al.
Publicado: (2020) -
Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance
por: Popovic, Ana, et al.
Publicado: (2022) -
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma
por: Berestjuk, Ilona, et al.
Publicado: (2021) -
Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis
por: Ruetsch-Chelli, Caroline, et al.
Publicado: (2022) -
Effects on Melanoma Cell Lines Suggest No Significant Risk of Melanoma Under Cladribine Treatment
por: Lebrun-Frenay, Christine, et al.
Publicado: (2020)